Quick Answer
RHYTHM PHARMACEUTICALS, INC. reported Net Income of -$196.54 million for fiscal year 2025.
RHYTHM PHARMACEUTICALS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$196.54M | +24.6% |
| 2024 | -$260.60M | -41.1% |
| 2023 | -$184.68M | -2.0% |
| 2022 | -$181.12M | -160.2% |
| 2021 | -$69.61M | +48.0% |
| 2020 | -$134.00M | +4.8% |
| 2019 | -$140.73M | -90.0% |
| 2018 | -$74.06M | -119.7% |
| 2017 | -$33.71M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$52.90M | -21.2% | -13.4% |
| June 30, 2025 | -$46.63M | -44.5% | +5.8% |
| March 31, 2025 | -$49.50M | +65.0% | -13.4% |
| September 30, 2024 | -$43.64M | +1.2% | -35.3% |
| June 30, 2024 | -$32.26M | +30.9% | +77.2% |
| March 31, 2024 | -$141.37M | -170.9% | -220.1% |
| September 30, 2023 | -$44.16M | -8.1% | +5.4% |
| June 30, 2023 | -$46.70M | -3.8% | +10.5% |
- RHYTHM PHARMACEUTICALS, INC. showed an increase of +24.6% in Net Income compared to the prior fiscal year.
- Over the 2017–2025 period, RHYTHM PHARMACEUTICALS, INC.’s net income has declined by 483.0% (from -$33.71 million to -$196.54 million).
- The most recent figure is from RHYTHM PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: